ATE369144T1 - Verfahren zur steigerung des haarwuchses durch wnt polypeptid - Google Patents
Verfahren zur steigerung des haarwuchses durch wnt polypeptidInfo
- Publication number
- ATE369144T1 ATE369144T1 AT01926479T AT01926479T ATE369144T1 AT E369144 T1 ATE369144 T1 AT E369144T1 AT 01926479 T AT01926479 T AT 01926479T AT 01926479 T AT01926479 T AT 01926479T AT E369144 T1 ATE369144 T1 AT E369144T1
- Authority
- AT
- Austria
- Prior art keywords
- hair growth
- wnt polypeptide
- wnt
- increase hair
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0627—Hair cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19377100P | 2000-03-31 | 2000-03-31 | |
US26169001P | 2001-01-12 | 2001-01-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE369144T1 true ATE369144T1 (de) | 2007-08-15 |
Family
ID=26889330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01926479T ATE369144T1 (de) | 2000-03-31 | 2001-03-30 | Verfahren zur steigerung des haarwuchses durch wnt polypeptid |
Country Status (9)
Country | Link |
---|---|
US (4) | US6924141B2 (de) |
EP (1) | EP1267616B1 (de) |
JP (3) | JP4813734B2 (de) |
AT (1) | ATE369144T1 (de) |
AU (2) | AU5301201A (de) |
CA (1) | CA2403817C (de) |
DE (1) | DE60129799T2 (de) |
ES (1) | ES2290125T3 (de) |
WO (1) | WO2001074164A1 (de) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE369144T1 (de) * | 2000-03-31 | 2007-08-15 | Gen Hospital Corp | Verfahren zur steigerung des haarwuchses durch wnt polypeptid |
EP1368493A2 (de) * | 2001-03-07 | 2003-12-10 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Identifizierung und verwendung von inhibitoren der haarbildung |
US20050130181A1 (en) * | 2001-05-18 | 2005-06-16 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA) |
CA2482940A1 (en) * | 2002-04-17 | 2003-10-23 | Taisho Pharmaceuticals Co., Ltd. | Hair growth tonic |
EP1546392A4 (de) * | 2002-08-02 | 2006-05-24 | Stratatech Corp | Spezies-spezifischer dna-nachweis |
AU2003282244B2 (en) * | 2002-11-14 | 2008-11-20 | Aderans Research Institute, Inc. | Cultivation of hair inductive cells |
WO2004076642A2 (en) * | 2003-02-27 | 2004-09-10 | The Rockefeller University | Method for modulating epithelial stem cell lineage |
DE602004026898D1 (de) | 2003-10-10 | 2010-06-10 | Deutsches Krebsforsch | Zusammensetzungen für die diagnose und therapie von erkrankungen, die im zusammenhang mit einer anomalen expression von futrinen (r-spondinen) stehen |
CN101061217A (zh) | 2004-02-27 | 2007-10-24 | 通用医疗公司 | 用于毛发生长的方法和组合物 |
WO2006026617A2 (en) * | 2004-08-30 | 2006-03-09 | Iken Tissue Therapeutics, Inc. | Compositions and methods of promoting hair growth |
AU2005279934A1 (en) * | 2004-08-30 | 2006-03-09 | Theregen, Inc. | Compositions and methods of promoting hair growth |
CA2580780A1 (en) * | 2004-09-21 | 2006-04-06 | Rhode Island Hospital, A Lifespan-Partner | Frizzled proteins and detection and treatment of cancer |
WO2006036175A2 (en) * | 2004-09-21 | 2006-04-06 | Rhode Island Hospital, A Lifespan-Partner | Wnt proteins and detection and treatment of cancer |
US7850960B2 (en) * | 2004-12-30 | 2010-12-14 | University Of Washington | Methods for regulation of stem cells |
JP2008179540A (ja) * | 2005-01-07 | 2008-08-07 | Noevir Co Ltd | 細胞分化、発生、増殖を制御する物質および該物質を含む細胞分化・発生・増殖調節剤 |
CN101128212A (zh) * | 2005-01-18 | 2008-02-20 | 国立大学法人京都大学 | 用于神经细胞再生的药物 |
WO2006105109A2 (en) * | 2005-03-29 | 2006-10-05 | The Trustees Of The University Of Pennsylvania | Methods for generating new hair follicles, treating baldness, and hair removal |
AU2012204059B2 (en) * | 2005-03-29 | 2015-01-15 | The Trustees Of The University Of Pennsylvania | Methods for generating new hair follicles, treating baldness and hair removal |
WO2010056759A1 (en) * | 2008-11-12 | 2010-05-20 | The Trustees Of The University Of Pennsylvania | Fibroblast growth factor-9 promotes hair follicle regeneration after wounding |
EP3409296A1 (de) * | 2005-04-07 | 2018-12-05 | The Trustees of the University of Pennsylvania | Verfahren zur erhöhung der funktion eines aav-vektors |
WO2006124356A2 (en) * | 2005-05-16 | 2006-11-23 | The Rockefeller University | Method for isolating dermal papilla cells and uses thereof |
US20070148138A1 (en) | 2005-11-22 | 2007-06-28 | Aderans Research Institute, Inc. | Hair follicle graft from tissue engineered skin |
EP2007877B1 (de) | 2006-02-28 | 2013-04-17 | The Trustees of Columbia University in the City of New York | Verfahren für kompakte aggregation von hautzellen |
GB0605450D0 (en) | 2006-03-17 | 2006-04-26 | Intercytex Ltd | Cell co-culture |
ES2641528T3 (es) | 2006-06-27 | 2017-11-10 | Shiseido Company, Limited | Masa celular capaz de servir como estructura de tipo órgano primitivo compuesta por una diversidad de tipos de células de origen somático |
EP2077819A4 (de) * | 2006-09-28 | 2011-05-25 | Follica Inc | Verfahren, kits und zusammensetzungen zur erzeugung von neuen haarfollikeln und wachsendem haar |
US7922688B2 (en) | 2007-01-08 | 2011-04-12 | Restoration Robotics, Inc. | Automated delivery of a therapeutic or cosmetic substance to cutaneous, subcutaneous and intramuscular tissue regions |
US8580236B2 (en) * | 2007-03-19 | 2013-11-12 | Richard P. De Maria | Hair sustaining formulation |
US8158757B2 (en) | 2007-07-02 | 2012-04-17 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for treating and diagnosing cancer |
JP5300273B2 (ja) * | 2008-01-21 | 2013-09-25 | 株式会社 資生堂 | ヒトWnt3a遺伝子形質転換細胞 |
US20100166824A1 (en) * | 2008-01-30 | 2010-07-01 | Histogen, Inc. | Extracellular matrix compositions |
US8535913B2 (en) | 2008-01-30 | 2013-09-17 | Histogen, Inc. | Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells |
US8530415B2 (en) * | 2008-01-30 | 2013-09-10 | Histogen, Inc. | Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions |
BRPI0906972B1 (pt) * | 2008-01-30 | 2021-09-08 | Histogen, Inc | Métodos para produção de composições de matriz extracelular e para produção de uma proteína wnt e de um fator de crescimento endotelial vascular |
US8524494B2 (en) | 2008-01-30 | 2013-09-03 | Histogen, Inc. | Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro |
FR2936255B1 (fr) * | 2008-09-19 | 2010-10-15 | Galderma Res & Dev | Modulateurs de fzd2 dans le traitement de l'alopecie |
US20120046242A1 (en) * | 2008-12-24 | 2012-02-23 | Massachusetts Institute Of Technology | Molecular activators of the wnt/beta-catenin pathway |
KR101198918B1 (ko) * | 2009-09-01 | 2012-11-07 | (주)케어젠 | Wnt10?유래 펩타이드 및 그의 용도 |
EP3508197A1 (de) * | 2009-10-21 | 2019-07-10 | Otonomy, Inc. | Modulation der geltemperatur poloxamerhaltiger formulierungen |
KR101209117B1 (ko) | 2010-03-25 | 2012-12-06 | (주)케어젠 | 변형된 wnt10?유래 펩타이드 및 그의 용도 |
AU2011268139B2 (en) * | 2010-06-18 | 2014-09-04 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Hair follicle neogenesis |
JP2014500275A (ja) | 2010-12-06 | 2014-01-09 | フォリカ,インコーポレイテッド | 禿頭症を治療するため、および毛髪の成長を促進するための方法 |
WO2012174280A2 (en) | 2011-06-15 | 2012-12-20 | The Regents Of The University Of California | Methods and compositions for modulating myofibroblast activities |
CN106167526A (zh) | 2011-07-15 | 2016-11-30 | 昂考梅德药品有限公司 | Rspo结合剂和其应用 |
KR101285259B1 (ko) | 2011-08-04 | 2013-07-11 | (주)케어젠 | Wnt 계열 유래 펩타이드 및 이의 용도 |
MX2015000565A (es) | 2012-07-13 | 2015-04-10 | Oncomed Pharm Inc | Agentes de union de proteina de r-espondina humana (rspo3) y usos de los mismos. |
CN105343073B (zh) * | 2013-03-07 | 2018-05-04 | 中国科学院上海生命科学研究院 | 一种可用作Wnt信号途径激活剂的化合物及其制备与应用 |
US10478526B2 (en) | 2013-05-03 | 2019-11-19 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Skin substitutes and methods for hair follicle neogenesis |
US11142577B2 (en) | 2014-09-12 | 2021-10-12 | The Board Of Trustees Of The Leland Stanford Junior University | WNT signaling agonist molecules |
CA2961374A1 (en) | 2014-09-16 | 2016-03-24 | Oncomed Pharmaceuticals, Inc. | Treatment of fibrotic diseases |
WO2016112343A1 (en) * | 2015-01-09 | 2016-07-14 | The Board Of Trustees Of The Leland Stanford Junior University | R-spondin agonist-mediated hair growth |
SG10201910821XA (en) | 2016-12-30 | 2020-01-30 | Frequency Therapeutics Inc | 1h-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells |
CN106727682A (zh) * | 2017-01-20 | 2017-05-31 | 李玉红 | 一种用于治疗脱发的制剂 |
JP2020516282A (ja) * | 2017-04-11 | 2020-06-11 | フリークエンシー セラピューティクス インコーポレイテッド | 毛包幹細胞増殖のための方法 |
EP3638238A4 (de) | 2017-06-15 | 2021-03-10 | Belite Bio, Inc | Verfahren zur behandlung von stoffwechselkrankheiten mit kondensierten bicyclischen pyrazolen |
TW201904968A (zh) | 2017-06-15 | 2019-02-01 | 開曼群島商貝利特生物股份有限公司 | 以三唑并吡啶治療rbp4相關疾病之方法 |
KR20200103660A (ko) * | 2017-11-16 | 2020-09-02 | 에이비타 바이오메디컬, 인크. | 세포막 결합된 신호전달 인자의 용도 |
AU2018393076A1 (en) | 2017-12-19 | 2020-07-02 | Surrozen Operating, Inc. | Anti-LRP5/6 antibodies and methods of use |
US11773171B2 (en) | 2017-12-19 | 2023-10-03 | Surrozen Operating, Inc. | WNT surrogate molecules and uses thereof |
JP7418332B2 (ja) | 2017-12-19 | 2024-01-19 | スロゼン オペレーティング, インコーポレイテッド | 抗フリズルド抗体及び使用方法 |
TWI665217B (zh) * | 2018-03-07 | 2019-07-11 | 臺鹽實業股份有限公司 | 膠原蛋白衍生胜肽及其用於製備促進生髮組成物之用途 |
GB201816902D0 (en) | 2018-10-17 | 2018-11-28 | Hairclone Ltd | Hair Rejuvenation |
KR102242840B1 (ko) * | 2019-04-04 | 2021-04-23 | 주식회사 비알팜 | 탈모 방지 또는 발모 촉진용 조성물 |
CN114364382A (zh) | 2019-07-08 | 2022-04-15 | 倍亮生物有限责任公司 | Rbp4抑制剂的制剂和使用方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5091173A (en) * | 1989-06-29 | 1992-02-25 | The University Of Dundee | Hair growth composition |
US5208145A (en) * | 1991-05-06 | 1993-05-04 | The Salk Institute For Biological Studies | Assay for the presence, in cultured cells, of functional ligand-gated channels, and substances which enhance intracellular lithium accumulation by cultured cells via such channels |
US5549674A (en) * | 1992-03-02 | 1996-08-27 | The Regents Of The University Of Michigan | Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
WO1995017416A1 (en) | 1993-12-22 | 1995-06-29 | Merck & Co., Inc. | Dna encoding the wnt-x growth factor |
JP3573488B2 (ja) * | 1994-04-11 | 2004-10-06 | 独立行政法人 科学技術振興機構 | 毛乳頭細胞の長期継代培養法 |
JP2991620B2 (ja) * | 1994-08-30 | 1999-12-20 | 科学技術振興事業団 | 細胞活動の制御方法 |
AU7672996A (en) | 1995-11-13 | 1997-06-05 | Regents Of The University Of California, The | Methods and compositions for hair growth promotion |
EP1054899A2 (de) * | 1998-02-21 | 2000-11-29 | Max-Delbrück-Centrum Für Molekulare Medizin | Mittel zur therapie von menschlichen erkrankungen, ausgehend von beta-catenin, seine herstellung und seine verwendung |
US6485972B1 (en) * | 1998-10-15 | 2002-11-26 | President And Fellows Of Harvard College | WNT signalling in reproductive organs |
US6159950A (en) | 1998-10-16 | 2000-12-12 | Cornell Research Foundation, Inc. | Method of modulating hair growth |
WO2000031134A1 (en) | 1998-11-20 | 2000-06-02 | Arch Development Corporation | Regulation of hair follicle morphogenesis based on beta-catenin |
ATE369144T1 (de) * | 2000-03-31 | 2007-08-15 | Gen Hospital Corp | Verfahren zur steigerung des haarwuchses durch wnt polypeptid |
-
2001
- 2001-03-30 AT AT01926479T patent/ATE369144T1/de not_active IP Right Cessation
- 2001-03-30 EP EP01926479A patent/EP1267616B1/de not_active Expired - Lifetime
- 2001-03-30 AU AU5301201A patent/AU5301201A/xx active Pending
- 2001-03-30 CA CA2403817A patent/CA2403817C/en not_active Expired - Lifetime
- 2001-03-30 AU AU2001253012A patent/AU2001253012B2/en not_active Expired
- 2001-03-30 JP JP2001571928A patent/JP4813734B2/ja not_active Expired - Lifetime
- 2001-03-30 WO PCT/US2001/010164 patent/WO2001074164A1/en active IP Right Grant
- 2001-03-30 US US09/822,722 patent/US6924141B2/en not_active Expired - Lifetime
- 2001-03-30 DE DE60129799T patent/DE60129799T2/de not_active Expired - Lifetime
- 2001-03-30 ES ES01926479T patent/ES2290125T3/es not_active Expired - Lifetime
-
2004
- 2004-03-02 US US10/791,368 patent/US20040170611A1/en not_active Abandoned
-
2005
- 2005-05-13 US US11/129,215 patent/US7175842B2/en not_active Expired - Lifetime
-
2007
- 2007-02-02 US US11/701,835 patent/US7985587B2/en not_active Expired - Fee Related
-
2011
- 2011-06-14 JP JP2011132510A patent/JP5580252B2/ja not_active Expired - Lifetime
-
2014
- 2014-05-12 JP JP2014098315A patent/JP5960749B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6924141B2 (en) | 2005-08-02 |
EP1267616A4 (de) | 2003-07-16 |
JP4813734B2 (ja) | 2011-11-09 |
CA2403817C (en) | 2012-05-29 |
US7175842B2 (en) | 2007-02-13 |
EP1267616B1 (de) | 2007-08-08 |
DE60129799T2 (de) | 2008-04-30 |
JP2004500407A (ja) | 2004-01-08 |
US20050271632A1 (en) | 2005-12-08 |
DE60129799D1 (de) | 2007-09-20 |
CA2403817A1 (en) | 2001-10-11 |
JP5580252B2 (ja) | 2014-08-27 |
US20080286261A1 (en) | 2008-11-20 |
JP2014159471A (ja) | 2014-09-04 |
US20020114772A1 (en) | 2002-08-22 |
WO2001074164A9 (en) | 2002-01-10 |
WO2001074164A1 (en) | 2001-10-11 |
ES2290125T3 (es) | 2008-02-16 |
US20040170611A1 (en) | 2004-09-02 |
JP2011207908A (ja) | 2011-10-20 |
EP1267616A1 (de) | 2003-01-02 |
AU2001253012B2 (en) | 2006-02-23 |
AU5301201A (en) | 2001-10-15 |
US7985587B2 (en) | 2011-07-26 |
JP5960749B2 (ja) | 2016-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE369144T1 (de) | Verfahren zur steigerung des haarwuchses durch wnt polypeptid | |
ATE375999T1 (de) | Zusammensetzungen und verfahren zur behandlung von diabetes | |
WO2003089457A3 (en) | Peptide inhibitors of protein kinase c ϝ for pain management | |
ATE453653T1 (de) | Platinkomplexe zur behandlung von tumoren | |
ATE308045T1 (de) | Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür | |
ATE471722T1 (de) | Verfahren zur regulierung von angiogenese mit apelin-zusammensetzungen | |
NO20055309D0 (no) | Slurp-1 samrnensetninger og fremgangsmater for anvendelse derav | |
ATE416619T1 (de) | Verfahren zur dearomatisierung von molkeprotein | |
DE60037886D1 (de) | Verfahren zur reinigung von rekombinanten proteinen, welche wachstumshormon antagonisten sind, mittels wässriger zweiphasen-extraktion | |
DK0786004T3 (da) | Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase | |
ATE406438T1 (de) | Menschliches homolog aus der familie der metalloproteasen | |
DE602004014799D1 (de) | System und assoziiertes verfahren zur bestimmung der authentifikationspriorität zwischen einrichtungen | |
DE60325194D1 (de) | Methoden zur verwendung von lamellaren körpern für therapeutische zwecke | |
DE59809283D1 (de) | Inhibitoren für den urokinaserezeptor | |
ATE517629T1 (de) | Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems | |
TR200102655T2 (tr) | Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen. | |
DE602004023811D1 (de) | Verfahren zur modularen Potenzierung zur Entschlüsselung bzw. zur Erzeugung von digitalen Signaturen | |
DE602004003966D1 (de) | Verbessertes verfahren zur herstellung von alpha-polymorphem eletriptan hydrobromid | |
MXPA06013176A (es) | Dominios semejantes al factor de crecimiento epidermico de mucina 3. | |
ATE402948T1 (de) | Verfahren zur aufreinigung eines nichtimmunoglobulinproteins, das eine immunoglobulinähnliche (ig-like) domäne enthält | |
ATE512983T1 (de) | Rezeptor für das tgr3-like protein | |
DE60119458D1 (de) | Vorrichtung zur Feststellung der genetischen Sequenz von Biopolymeren | |
DE50205026D1 (de) | Verfahren zur herstellung von n-substituierten 2,6-dialkylmorpholinen | |
DE60011785D1 (de) | Verfahren zur herstellung von proteinen in wirtszellen unter verwendung von chaperoninen | |
DE60323072D1 (de) | Verfahren zur vorbereitung einer soojichim akupunktur mit körperkopie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |